3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
2
Phase 2
1
Status
Recruiting
3
Completed
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Plasma cell
3
Other hematologic neoplasm
3
Lymphoid
3
Tumor-Agnostic
2
Thoracic
2
Myeloid
2
Head & Neck
2
Gastrointestinal
2
Endocrine
2
Dermatologic
2
Sarcoma
1
Gynecologic
1
CNS
1
Conditions
Hematologic Neoplasms
3
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Neoplasms
2
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Laryngeal Neoplasms
1
Glioma
1
Erdheim-Chester Disease
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
venetoclax
190
Cyclophosphamide
124
Azacitidine
112
Cytarabine
108
fludarabine
92
Specimen Handling
75
Biopsy
54
Daunorubicin
42
Methotrexate
40
Dexamethasone
37
Rituximab
34
blinatumomab
32
Vincristine
31
Decitabine
31
fludarabine phosphate
30
Injections
28
Granulocyte Colony-Stimulating Factor
28
Magnetic Resonance Spectroscopy
27
Whole-Body Irradiation
26
obinutuzumab
25
Idarubicin
25
acalabrutinib
23
Mycophenolic Acid
23
Prednisone
22
Melphalan
21
Busulfan
21
gilteritinib
19
Stem Cell Transplantation
19
Doxorubicin
19
ibrutinib
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
cobimetinib
×
Other hematologic neoplasm
×
Clear all
NCT05722886
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
825 enrolled
NCT05768178
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled
NCT05159245
2024-07-15
FINPROVE
Helsinki University Central Hospital
Phase 2
Recruiting
250 enrolled